| Q33939486 | 5-Azacytidine is able to induce the conversion of teratocarcinoma-derived mesenchymal cells into epithelia cells |
| Q41082994 | A 210 kDa nuclear matrix protein is a functional part of the mitotic spindle; a microinjection study using SPN monoclonal antibodies |
| Q80149958 | A European interlaboratory testing of three well-known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow |
| Q72693462 | A comprehensive catalogue of cytokeratins |
| Q41674142 | A human bronchial epithelial cell strain with unusualin vitro growth potential which undergoes neoplastic transformation after SV40 T antigen gene transfection |
| Q72733395 | A monoclonal antibody recognizes an epitope common to an avian-specific nuclear antigen and to cytokeratins |
| Q72750461 | A monoclonal antibody recognizing a keratin filament protein in a subset of transitional and glandular epithelia |
| Q42511368 | A monoclonal antibody that detects myoepithelial cells in exocrine glands, basal cells in other epithelia and basal and suprabasal cells in certain hyperplastic tissues |
| Q41626789 | A novel monoclonal antibody to cytokeratin 18 with reactivity toward lung squamous cell carcinomas and adenocarcinomas of various sites |
| Q41677493 | A series of 14 new monoclonal antibodies to keratins: Characterization and value in diagnostic histopathology |
| Q42477773 | Alteration of cytokeratin expression in oral lichen planus |
| Q72076694 | An Immunohistochemical Study on the Cytogenetic Origin of Pulmonary Multinucleate Giant Cells in Porcine Dermatosis Vegetans |
| Q68978293 | An immunocytochemical study of fetal cells at the maternal-placental interface using monoclonal antibodies to keratins, vimentin and desmin |
| Q40076292 | Antibodies to Intermediate Filament Proteins in the Diagnosis and Classification of Human Tumors |
| Q68951399 | Antibodies to cytokeratin and vimentin in testicular tumour diagnosis |
| Q42487610 | Antigenic interrelationship between the 40-kilodalton cytokeratin polypeptide and desmoplakins |
| Q41430347 | Change of cytokeratin filament organization during the cell cycle: selective masking of an immunologic determinant in interphase PtK2 cells. |
| Q42465936 | Changes in cytokeratin expression in gingiva during inflammation |
| Q68010176 | Changes in the distribution of intermediate filament proteins and collagen IV in fetal and adult human pancreas. I. Localization of cytokeratin polypeptides |
| Q36271844 | Cloning of cDNAs specifying vitamin A-responsive human keratins |
| Q68946531 | Co-expression of cytokeratin and vimentin intermediate-sized filaments in renal cell carcinomas. Comparative study of the intermediate-sized filament distribution in renal cell carcinomas and normal human kidney |
| Q24313487 | Comparison of mouse and human keratin 18: a component of intermediate filaments expressed prior to implantation |
| Q36213240 | Cytokeratin No. 9, an epidermal type I keratin characteristic of a special program of keratinocyte differentiation displaying body site specificity. |
| Q67467931 | Cytokeratin and vimentin heterogeneity in human cornea |
| Q34293501 | Cytokeratin expression in human thymus: immunohistochemical mapping |
| Q41251012 | Cytokeratin expression in normal salivary glands and in cystadenolymphomas demonstrated by monoclonal antibodies against selective cytokeratin polypeptides |
| Q42466690 | Cytokeratin polypeptide expression in a cloacogenic carcinoma and in the normal anal canal epithelium |
| Q42487769 | Cytokeratin polypeptides expression in different epithelial elements of human salivary glands |
| Q35818550 | Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines |
| Q38152736 | Cytoskeleton-associated proteins: their role as cellular integrators in the neoplastic process |
| Q70333739 | Diagnostic value of intermediate filament antibodies in clinical cytology |
| Q69020083 | Differential diagnosis of benign epithelial proliferations and carcinomas of the breast using antibodies to cytokeratins |
| Q42487621 | Differential expression of keratin 19 in normal human epithelial tissues revealed by monospecific monoclonal antibodies |
| Q71140770 | Disseminated epithelial tumor cells in bone marrow of patients with esophageal cancer: detection and prognostic significance |
| Q72087680 | Expression of cytokeratins in squamous cell carcinomas of the larynx: immunohistochemical analysis and correlation with prognostic factors |
| Q36218601 | Expression of simple epithelial type cytokeratins in stratified epithelia as detected by immunolocalization and hybridization in situ |
| Q42475979 | Extracellular matrix-dependent differentiation of rabbit tracheal epithelial cells in primary culture |
| Q70989320 | Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases |
| Q44609262 | Identification of the conserved, conformation-dependent cytokeratin epitope recognized by monoclonal antibody (lu-5). |
| Q35856350 | Immunocytochemical analysis of Ewing's tumors. Patterns of expression of intermediate filaments and desmosomal proteins indicate cell type heterogeneity and pluripotential differentiation |
| Q71643329 | Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancer |
| Q34305979 | Immunocytochemical double staining of cytokeratin and prostate specific antigen in individual prostatic tumour cells |
| Q68935881 | Immunohistochemical characterization of an anti-epithelial monoclonal antibody (mAB lu-5) |
| Q42487841 | Immunohistochemical demonstration of cytokeratins in the human prostate |
| Q41980306 | Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies |
| Q35858467 | Immunohistochemical study of nasopharyngeal carcinoma using monoclonal keratin antibodies |
| Q69004256 | Immunohistochemistry in the diagnosis of malignant mesothelioma |
| Q67691608 | Immunohistochemistry of porcine skin |
| Q53479191 | Immunoreactivity to cytokeratins in non-epithelial cells in deep gastric ulcer |
| Q41483072 | Intermediate filament cytoskeleton of amnion epithelium and cultured amnion epithelial cells: expression of epidermal cytokeratins in cells of a simple epithelium |
| Q68194811 | Intermediate filaments in cytological specimens of thyroid tumors |
| Q36212540 | Intermediate filaments in non-neuronal cells of invertebrates: isolation and biochemical characterization of intermediate filaments from the esophageal epithelium of the mollusc Helix pomatia |
| Q58439290 | Intermediate filaments of normal and neoplastic tissues of the female genital tract with emphasis on problems of differential tumor diagnosis |
| Q33284286 | Intermediate filaments: a historical perspective |
| Q41900586 | Keratin polypeptides in malignant epithelial liver tumors. Differential diagnostic and histogenetic aspects |
| Q41856635 | Keratin subsets in spindle cell sarcomas. Keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins |
| Q41532268 | Lack of inter‐species reactivity between antigens and antibodies is overcome by protease treatment of Western blots |
| Q41503119 | Localization of low-sulfur keratin proteins in the wool follicle using monoclonal antibodies |
| Q39377901 | Merkel cells in ontogenesis of human nails |
| Q34373873 | Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies |
| Q67705312 | Micrometastatic tumour cells in bone marrow of patients with gastric cancer: Methodological aspects of detection and prognostic significance |
| Q72722542 | Monoclonal antibodies specific for glial fibrillary acidic (GFA) protein and for each of the neurofilament triplet polypeptides |
| Q33934133 | Monoclonal antibodies to desmin, the muscle-specific intermediate filament protein |
| Q42737822 | Monoclonal antibodies with different specificities against cytokeratins. An immunohistochemical study of normal tissues and tumors |
| Q67703991 | Morphologic correlation between liver epithelium and mesenchyme allows insight into histogenesis of focal nodular hyperplasia (FNH) of the liver |
| Q38573682 | Morphology and histogenesis of squamous cell metaplasia of the rat lung after chronic exposure to a pyrolized pitch condensate and/or carbon black, or to combinations of pyrolized pitch condensate, carbon black and irritant gases |
| Q38589651 | N-Methyl-N-nitrosourea as a mammary carcinogenic agent. |
| Q42489283 | Patterns of cytokeratin and vimentin expression in the human eye. |
| Q42487363 | Pleomorphic adenomas, adenoid cystic carcinomas and adenolymphomas of salivary glands analysed by a monoclonal antibody against myoepithelial/basal cells. An immunohistochemical study |
| Q35818900 | Smooth muscle cells can express cytokeratins of "simple" epithelium. Immunocytochemical and biochemical studies in vitro and in vivo. |
| Q37473519 | Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epithelia |
| Q35835485 | The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. |
| Q33940121 | Tissue polypeptide antigen (TPA) is related to the non-epidermal keratins 8, 18 and 19 typical of simple and non-squamous epithelia: re-evaluation of a human tumor marker |
| Q67694933 | UNME/K1: an IgG2a monoclonal antibody specific to cytokeratin of human urinary bladder squamous cell carcinoma |
| Q42776488 | Value of human amniotic epithelial cells in tissue engineering for cornea |
| Q47238125 | Vessel size-dependent expression of intermediate-sized filaments, calponin, and h-caldesmon in smooth muscle cells of human coronary arteries |
| Q41901268 | Villin--a marker of brush border differentiation and cellular origin in human renal cell carcinoma |